These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38662226)

  • 1. The survival benefit of metastasectomy for metastatic non-clear cell renal cell carcinoma: a retrospective cohort study.
    Dai J; He B; Zhang Y; Zhang H; Hu X; Xu L; Ni Y; Zhang X; Sun G; Zeng H; Shen P; Liu Z
    World J Urol; 2024 Apr; 42(1):259. PubMed ID: 38662226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how?
    Marvaso G; Corrao G; Oneta O; Pepa M; Zaffaroni M; Corso F; Gandini S; Cecconi A; Zerini D; Mazzola GC; Augugliaro M; Cossu Rocca M; Verri E; Cattani F; La Fauci F; Bergamaschi L; Luzzago S; Mistretta AF; Musi G; Nolè F; De Cobelli O; Orecchia R; Jereczek-Fossa BA
    Clin Transl Oncol; 2021 Aug; 23(8):1717-1726. PubMed ID: 33687659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes for Patients after Resection of Pulmonary Metastases from Clear Cell Renal Cell Carcinoma: 18 Years of Experience.
    Procházková K; Vodička J; Fichtl J; Krákorová G; Šebek J; Roušarová M; Hošek P; Brookman May SD; Hes O; Hora M; Třeška V
    Urol Int; 2019; 103(3):297-302. PubMed ID: 31434090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical treatment of atypical metastasis from renal cell carcinoma (RCC).
    Antonelli A; Arrighi N; Corti S; Legramanti S; Zanotelli T; Cozzoli A; Cunico SC; Simeone C
    BJU Int; 2012 Dec; 110(11 Pt B):E559-63. PubMed ID: 22639956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival and impact of clinical prognostic factors in surgically treated metastatic renal cell carcinoma.
    Tosco L; Van Poppel H; Frea B; Gregoraci G; Joniau S
    Eur Urol; 2013 Apr; 63(4):646-52. PubMed ID: 23041360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Metastasectomy in Patients with Renal Cell Carcinoma with Sarcomatoid Dedifferentiation: A Matched Controlled Analysis.
    Thomas AZ; Adibi M; Slack RS; Borregales LD; Merrill MM; Tamboli P; Sircar K; Jonasch E; Tannir NM; Matin SF; Wood CG; Karam JA
    J Urol; 2016 Sep; 196(3):678-84. PubMed ID: 27036304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clear cell and non-clear cell renal cell carcinoma in young adults: clinicopathological features, survival outcomes and prognostic factors.
    Xue Z; Tang S; Ou J; Fang Y; Qiu M; Hong K; Tian X; Zhang H; Liu C; Ma L; Zhang S
    World J Urol; 2024 May; 42(1):364. PubMed ID: 38819448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery.
    Leibovich BC; Lohse CM; Cheville JC; Zaid HB; Boorjian SA; Frank I; Thompson RH; Parker WP
    Eur Urol; 2018 May; 73(5):772-780. PubMed ID: 29398265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of cytoreductive nephrectomy on survival outcomes in patients treated with tyrosine kinase inhibitors for metastatic renal cell carcinoma in a real-world cohort.
    Janisch F; Hillemacher T; Fuehner C; D'Andrea D; Meyer CP; Klotzbücher T; Kienapfel C; Vetterlein MW; Kimura S; Abufaraj M; Dahlem R; Shariat SF; Fisch M; Rink M
    Urol Oncol; 2020 Sep; 38(9):739.e9-739.e15. PubMed ID: 32576526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of metastasectomy in renal cell carcinoma in the postcytokine therapy era.
    Ishihara H; Takagi T; Kondo T; Fukuda H; Tachibana H; Yoshida K; Iizuka J; Kobayashi H; Ishida H; Tanabe K
    Urol Oncol; 2021 Jan; 39(1):77.e17-77.e25. PubMed ID: 32863124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Positive Lymph Nodes in Patients with Renal Cell Carcinoma and Tumor Thrombus Undergoing Nephrectomy and Thrombectomy.
    Xiao R; Xu C; Ge L; He W; Yang B; Liu L; Liu C; Ma L
    Urol Int; 2021; 105(7-8):657-665. PubMed ID: 33882508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of metastasectomy on survival of patients with synchronous metastatic renal cell cancer in Finland: A nationwide study.
    Laru L; Ronkainen H; Ohtonen P; Vaarala MH
    Scand J Surg; 2024 Sep; 113(3):219-228. PubMed ID: 38433655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary metastasectomy in patients with renal cell carcinoma: a single-institution experience.
    Kawashima A; Nakayama M; Oka D; Sato M; Hatano K; Mukai M; Nagahara A; Nakai Y; Takayama H; Inoue M; Shiono H; Nishimura K; Okumura M; Nonomura N
    Int J Clin Oncol; 2011 Dec; 16(6):660-5. PubMed ID: 21556800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of metastasectomy on overall survival in metastatic renal cell carcinoma: A systematic review and meta-analysis.
    Hsieh PY; Hung SC; Li JR; Wang SS; Yang CK; Chen CS; Lu K; Cheng CL; Chiu KY
    Urol Oncol; 2021 Jul; 39(7):422-430. PubMed ID: 33934963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefit of on nephrectomy for treating metastatic renal cell carcinoma.
    González-Ruiz de León C; Pellejero-Pérez P; Quintás-Blanco A; García-Rodríguez J; Álvarez-Fernández C; Fernández-Gómez JM
    Actas Urol Esp; 2017 Jun; 41(5):338-342. PubMed ID: 28094071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete Surgical Metastasectomy of Renal Cell Carcinoma in the Post-Cytokine Era.
    Lyon TD; Thompson RH; Shah PH; Lohse CM; Boorjian SA; Costello BA; Cheville JC; Leibovich BC
    J Urol; 2020 Feb; 203(2):275-282. PubMed ID: 31393812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of complete metastasectomy in metastatic renal cell carcinoma patients: The Canadian Kidney Cancer information system experience.
    Dragomir A; Nazha S; Wood LA; Rendon RA; Finelli A; Hansen A; So AI; Kollmannsberger C; Basappa NS; Pouliot F; Soulières D; Heng DYC; Kapoor A; Tanguay S
    Urol Oncol; 2020 Oct; 38(10):799.e1-799.e10. PubMed ID: 32778475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer.
    Powles T; Blank C; Chowdhury S; Horenblas S; Peters J; Shamash J; Sarwar N; Boleti E; Sahdev A; O'Brien T; Berney D; Beltran L; Nathan P; Haanen J; Bex A
    Eur Urol; 2011 Sep; 60(3):448-54. PubMed ID: 21612860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic Review of the Role of Cytoreductive Nephrectomy in the Targeted Therapy Era and Beyond: An Individualized Approach to Metastatic Renal Cell Carcinoma.
    Bhindi B; Abel EJ; Albiges L; Bensalah K; Boorjian SA; Daneshmand S; Karam JA; Mason RJ; Powles T; Bex A
    Eur Urol; 2019 Jan; 75(1):111-128. PubMed ID: 30467042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of the primary tumor on the long-term results of pulmonary metastasectomy for metastatic renal cell carcinoma.
    Bölükbas S; Kudelin N; Eberlein M; Fisseler-Eckhoff A; Schirren J
    Thorac Cardiovasc Surg; 2012 Sep; 60(6):390-7. PubMed ID: 22207364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.